Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: Centre for Infectious Disease Research in Zambia
Street 1: Plot 5032 Great North Road
Street 2:
City: Lusaka
Province: Lusaka
Post Code: 10101
Country: Zambia
Phone: +260.211.242-257/258/259
Email: info@cidrz.org
Web Site: http://www.cidrz.org

Focal Point Contact Information

Salutation: Dr.
First Name: Stewart
Last Name: Reid
Title: Senior Advisor TB Program
Email: stewart.reid@cidrz.org
Phone: +260 966747677

Alternate Focal Point Contact Information

Salutation: Ms
First Name: Sisa
Last Name: Hatwiinda
Title: Project Coordinator
Email: sisa.hatwiinda@cidrz.org
Phone: +260 979228244

General Information

Board Constituency: Technical agencies
Organization Type - Primary: Academic / Research Institution
Organization Type - Secondary: None
Is your organization legally registered in your country: Yes
Organization Reach: National
Organization Description:
TB Research: The TB team has developed an exceptional environment for clinical research and conducts clinical trials, operations and public health research focused on the diagnosis and treatment of tuberculosis, and to assess the impact and outcomes of programmatic interventions to continually improve our activities. Studies address TB-related issues in diverse populations including prisoners, pregnant women, and HIV-infected adults and children. The CIDRZ portfolio of TB implementation science and clinical research has increased substantially over the past five years to 3.4 million USD with six funded projects. These include trials on treatment strategies for TB/HIV co-infected adult and paediatric patients (ACTG 5221, ACTG 5274), TB screening studies under the CDC-Public Health Evaluation (PHE) mechanism (LED Fluorescence microscopy field evaluations & TB screening in new ART enrollees), special populations’ studies: TB in pregnancy and Vitamin D levels in HIV/TB patients. Other TB-related research activities include field trials of Xpert MTB/RIF and development of a TB specimen repository for research on new diagnostics and biomarkers.

Laboratory Support
The TB laboratory is a regional reference facility with culture and molecular diagnostic capacity. The TB laboratory can handle up to 12,000 primary specimens per year employing: 1) florescence and ZN smear microscopy, 2) liquid (MGIT 960) and solid (LJ) culture, 3) line probe assay for rapid identification of mycobacteria and drug susceptibility testing, 4) blood culture capacity and 5) first line drug susceptibility testing using liquid culture system 6) Xpert MTB/RIF. All activities are covered with two EQA programs from UK NEQAS, INSTAND (Germany) and CAP (College of American Pathologists).
 
Total number of staff in your organization: 100 +
Number of full-time staff who are directly involved with TB: 100 +
Number of part-time staff who are directly involved with TB: 0
Number of volunteers who are directly involved with TB: 0
 
What is your organization's annual budget (USD) dedicated to TB? $1 MIL-$10 MIL
How did you hear about the Stop TB Partnership: Stop TB communications
If you were informed or referred by another partner of the Stop TB Partnership please tell us who:
Why do you wish join the Stop TB Partnership: Information on developments within the TB world
 
Are you a member of a Stop TB national partnership: No
Are you in contact with your national TB programme: Yes
Please tell us how your organization is contributing to your country's national TB control plan:
TB Service Programs: The CIDRZ TB team works closely with the Zambian Ministry of Health and the National TB Program to improve the screening, diagnosis and management of TB in HIV-infected patients in Lusaka, Southern, Western, and Eastern provinces. This team has led the rapid scale-up of TB services in HIV-infected patients: After starting with one pilot site in late 2005, the team revamped the program and expanded support to three additional sites in 2006. By 2007, annual funding tripled to 3.8 million USD and in 2008 and 2009 we rapidly expanded throughout Lusaka, Western, and Southern provinces to 254 government health centers in 12 districts. As of 28th February, 2011 the CIDRZ TB program has trained over 1,242 health workers and is supporting provider initiated testing and counseling (PITC) programs and clinical mentoring in 23 Lusaka District health centers; 122 health centers in Southern province; 71 health centers in Western province and 43 health centers in Eastern province. Other programmatic activities include a grant to implement a sustainable TB screening program for 11,000 Zambian prisoners under the TB REACH Initiative (Stop TB Partnership, WHO), a European Union program to build capacity for oversight and coordination of prison health services in Zambia and the CDC funded – 3I’s – Implementation which include intensified community case finding, comprehensive tuberculosis control in rural Zambia using Xpert MTB/Rif and enhancing tuberculosis services in Zambian prisons. Due to the team’s collective experience in implementing TB programs and their established relationships with the NTP and other TB partners in Zambia, it is in a strong position to implement future interventions of public health importance.
 

Geographical Reach

Which country is your headquarters located in: Zambia
Which WHO region is the main focus of your work: African
Which countries do you do operate in:
(This includes countries you are conducting activities in)
Zambia

Specializations

Advocacy
Delivery of health services and care
Research and Development
Technical Assistance

Specializations in Countries

Research and Development Zambia

Contribution

Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

Declaration

Declaration of interests:
none

Application date: June 25, 2010
Last updated: February 11, 2014